Zydus Lifesciences' Drug CUTX-101 Faces FDA Scrutiny

Zydus Lifesciences, a drug company, is dealing with a problem with one of its medicines called CUTX-101, which is for treating a rare disease in children called Menkes disease.

The US government's FDA, which checks if medicines are safe and effective, sent Zydus a letter saying they needed more information.

This means the FDA has questions about the medicine or the factory where it is made.

Zydus has already answered the FDA's questions and is waiting for a report to confirm that their factory follows all the rules.

Despite this, the company's stock went up a little in value, showing investors are still optimistic.